zofran
GSK pondering £7.5 billion drugs sale
May 30, 2014Sales and Marketing GSK, Paxil, ageing, drugs, established, imitrex, zofran
GlaxoSmithKline is looking to make more than £7 billion by selling off its ageing portfolio of established drugs. This is …
Latest content
Medtronic secures CE Mark for new cardiac pacing portfolio
October 30, 2026
Dermatology leader Doncker is new Onicor CEO
October 29, 2026
October 28, 2026
